Home NDC 61919-836 ALPRAZOLAM
Product NDC 61919-836
11-digit product format 619190836
Labeler code 61919
Product ID 61919-836_94deef57-a142-365d-e053-2995a90ab691
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name ALPRAZOLAM
Dosage form TABLET
Route ORAL
Labeler Direct_Rx
Application ANDA074174
Marketing category ANDA
Marketing start 2019-07-12
Marketing end 0000-00-00
Substance ALPRAZOLAM
Active strength 1 mg/1
Pharmacologic classes Benzodiazepine [EPC],Benzodiazepines [CS]
DEA schedule CIV
NDC exclude flag No
Listing certified through 2020-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 2 · 99 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded product product I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded product product D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 61919-836-60 I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 61919-836-60 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 61919-836-90 I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 61919-836-30 I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 61919-836-60 I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 61919-836-60 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 61919-836-90 I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 61919-836-30 I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 61919-836-60 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 61919-836-60 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 61919-836-90 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 61919-836-30 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 61919-836-60 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 61919-836-60 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 61919-836-90 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 61919-836-30 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 61919-836-60 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 61919-836-60 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 61919-836-90 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 61919-836-30 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 61919-836-60 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 61919-836-60 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 61919-836-90 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 61919-836-30 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 61919-836-60 I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 61919-836-60 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 61919-836-90 I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 61919-836-30 I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 61919-836-60 I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 61919-836-60 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 61919-836-90 I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 61919-836-30 I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 61919-836-60 I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A074174-001 ALPRAZOLAM ALPRAZOLAM 0.25MG TABLET / ORAL AB 1993-10-19 A074174-002 ALPRAZOLAM ALPRAZOLAM 0.5MG TABLET / ORAL AB 1993-10-19 A074174-003 ALPRAZOLAM ALPRAZOLAM 1MG TABLET / ORAL AB 1993-10-19 A074174-004 ALPRAZOLAM ALPRAZOLAM 2MG TABLET / ORAL AB 1993-10-19
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 164 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A074174-001 ALPRAZOLAM 0.25MG TABLET / ORAL AB 1993-10-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A074174-002 ALPRAZOLAM 0.5MG TABLET / ORAL AB 1993-10-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A074174-003 ALPRAZOLAM 1MG TABLET / ORAL AB 1993-10-19 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A074174-004 ALPRAZOLAM 2MG TABLET / ORAL AB 1993-10-19 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A074174-001 ALPRAZOLAM 0.25MG TABLET / ORAL AB 1993-10-19 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A074174-002 ALPRAZOLAM 0.5MG TABLET / ORAL AB 1993-10-19 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A074174-003 ALPRAZOLAM 1MG TABLET / ORAL AB 1993-10-19 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A074174-004 ALPRAZOLAM 2MG TABLET / ORAL AB 1993-10-19 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A074174-001 ALPRAZOLAM 0.25MG TABLET / ORAL AB 1993-10-19 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A074174-002 ALPRAZOLAM 0.5MG TABLET / ORAL AB 1993-10-19 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A074174-003 ALPRAZOLAM 1MG TABLET / ORAL AB 1993-10-19 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A074174-004 ALPRAZOLAM 2MG TABLET / ORAL AB 1993-10-19 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A074174-001 ALPRAZOLAM 0.25MG TABLET / ORAL AB 1993-10-19 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A074174-002 ALPRAZOLAM 0.5MG TABLET / ORAL AB 1993-10-19 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A074174-003 ALPRAZOLAM 1MG TABLET / ORAL AB 1993-10-19 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A074174-004 ALPRAZOLAM 2MG TABLET / ORAL AB 1993-10-19 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A074174-001 ALPRAZOLAM 0.25MG TABLET / ORAL AB 1993-10-19 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A074174-002 ALPRAZOLAM 0.5MG TABLET / ORAL AB 1993-10-19 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A074174-003 ALPRAZOLAM 1MG TABLET / ORAL AB 1993-10-19 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A074174-004 ALPRAZOLAM 2MG TABLET / ORAL AB 1993-10-19 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A074174-001 ALPRAZOLAM 0.25MG TABLET / ORAL AB 1993-10-19 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A074174-002 ALPRAZOLAM 0.5MG TABLET / ORAL AB 1993-10-19 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A074174-003 ALPRAZOLAM 1MG TABLET / ORAL AB 1993-10-19 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A074174-004 ALPRAZOLAM 2MG TABLET / ORAL AB 1993-10-19 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A074174-001 ALPRAZOLAM 0.25MG TABLET / ORAL AB 1993-10-19 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A074174-002 ALPRAZOLAM 0.5MG TABLET / ORAL AB 1993-10-19 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A074174-003 ALPRAZOLAM 1MG TABLET / ORAL AB 1993-10-19 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A074174-004 ALPRAZOLAM 2MG TABLET / ORAL AB 1993-10-19 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A074174-001 ALPRAZOLAM 0.25MG TABLET / ORAL AB 1993-10-19 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A074174-002 ALPRAZOLAM 0.5MG TABLET / ORAL AB 1993-10-19 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A074174-003 ALPRAZOLAM 1MG TABLET / ORAL AB 1993-10-19 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A074174-004 ALPRAZOLAM 2MG TABLET / ORAL AB 1993-10-19 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A074174-001 ALPRAZOLAM 0.25MG TABLET / ORAL AB 1993-10-19 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A074174-002 ALPRAZOLAM 0.5MG TABLET / ORAL AB 1993-10-19 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A074174-003 ALPRAZOLAM 1MG TABLET / ORAL AB 1993-10-19 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A074174-004 ALPRAZOLAM 2MG TABLET / ORAL AB 1993-10-19 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A074174-001 ALPRAZOLAM 0.25MG TABLET / ORAL AB 1993-10-19 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A074174-002 ALPRAZOLAM 0.5MG TABLET / ORAL AB 1993-10-19 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A074174-003 ALPRAZOLAM 1MG TABLET / ORAL AB 1993-10-19 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A074174-004 ALPRAZOLAM 2MG TABLET / ORAL AB 1993-10-19 d06236e962d9…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 148 observed states.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 61919-836-60 ALPRAZOLAM 60 in 1 BOTTLE TABLET 60 2 61919-836-90 ALPRAZOLAM 90 in 1 BOTTLE TABLET 90 2 61919-836-30 ALPRAZOLAM 30 in 1 BOTTLE TABLET 30 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 61919-836 ALPRAZOLAM TABLET [DIRECT_RX] 2 Legacy NDC, 2 package rows 20191015_8d7db610-3bac-6a1d-e053-2a95a90a3351.zip 61919-836 ALPRAZOLAM TABLET [DIRECT_RX] 1 Legacy NDC, 1 package rows 20190713_8d7e0add-0d61-1794-e053-2a95a90af82b.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Alprazolam ALPRAZOLAM ANI Pharmaceuticals, Inc. 38428a1b-718c-49cc-94ae-2e3644ba6256 2023-06-28 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 074174 application number: ANDA074174
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 61919-836-30 61919083630 30 TABLET in 1 BOTTLE (61919-836-30) 30 tablet 2019-07-12 0000-00-00 No No Current 61919-836-60 61919083660 60 TABLET in 1 BOTTLE (61919-836-60) 60 tablet 2019-07-12 0000-00-00 No No Current 61919-836-90 61919083690 90 TABLET in 1 BOTTLE (61919-836-90) 90 tablet 2019-07-12 0000-00-00 No No Current